{
  "docId": "019de073-cd7d-722a-8136-5a45a3cc0efe",
  "docSlug": "303c45082bb692ab214f73eda43168dc",
  "documentTitle": "NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "regulatory-filing",
  "documentKindLabel": "Regulatory filing",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 30,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a Gantt-style visualization to map drug development stages against specific clinical indications and future catalysts.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-cd7d-722a-8136-5a45a3cc0efe/6",
  "deckHref": "/decks/019de073-cd7d-722a-8136-5a45a3cc0efe",
  "deckJsonHref": "/decks/019de073-cd7d-722a-8136-5a45a3cc0efe.json",
  "deckAnchorHref": "/decks/019de073-cd7d-722a-8136-5a45a3cc0efe#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.02,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "Sources: Dong-A, Management projections. Notes: GPR119 (G Protein-Coupled Receptor 119); T2DM (Type 2 Diabetes Mellitus); NASH (Non-Alcoholic Steatohepatitis); GLP1R/GCGR (Glucagon-Like Peptide 1 Receptor/ Glucagon Receptor). 1. Assumes standalone development path in NASH; NeuroBo has option to pursue T2DM as an additional indication for DA-1241. 2. Remaining preclinical work will be carried out prior to the initiation of the Phase Ia trial.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3e67294-db6d-4e67-adce-ce4762175696",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "framework",
      "text": "Gantt chart showing clinical trial progression",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd36cba0-322f-4636-a1a0-f413e5fa804f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.31,
        "y": 0.76
      },
      "kind": "legend",
      "text": "Completed vs Upcoming trial status",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "385bf463-813f-44e8-a066-7254757b87e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.9,
        "x": 0.05,
        "y": 0.277
      },
      "kind": "table",
      "text": "Pipeline table with columns for Product, Preclinical, Phase I, Phase II (IIa/IIb), Global Rights, and Upcoming Catalysts.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c92cdaf8-b560-4a28-9b6a-9f59ca5f91ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Pipeline and Near-Term Catalysts",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5ec6a9e-f2d9-4968-8cb4-81f9a93765b2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Gantt chart",
      "slug": "gantt-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "7e70cff1-3b40-472d-bf76-118e57f5f039",
      "evidence": "Gantt chart showing clinical trial progression",
      "confidence": 0.9
    },
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "10f92d49-f389-44a7-b345-a356cc4c7d9f",
      "evidence": "Pipeline table with columns for Product, Preclinical, Phase I, Phase II (IIa/IIb), Global Rights, and Upcoming Catalysts",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "ffc19695-045d-4985-ab85-419de7165f68",
      "evidence": "Visual representation of project timelines across clinical phases.",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}